This time, she did the right thing, and those people were now afraid of getting into trouble, so the idea that supporting Sha Baiyun was to exonerate the "turtle" was implemented. A goal that is not too high appears directly in the document, and some people even hint that it is acceptable to pay more.

Sha Baiyun, who was very disappointed to them and gave support with the purpose of exculpating his own children, ended this sky-high infringement compensation lawsuit that everyone thought was extremely difficult in less than a month.

Sha Baiyun got an extremely favorable result. It only took just more than the normal purchase price of the patent to end the lawsuit and settle out of court. And it has also been formally granted a patent, and after three years, it is automatically bought out.

So, everyone was stunned, if it weren't for the fact that Sha Baiyun and Liu Minghao's ancestors had no overseas relationship for eight generations, someone would have given him a hat of internal and external collusion.

At the end of the lawsuit, Sha Baiyun officially took office and was restructured as the general manager of Hantian Pharmaceutical Group. In fact, this lawsuit is not complicated. It's nothing more than a patent that already has many alternatives abroad, and it's already somewhat outdated. Why? In foreign countries, the economy has reached a new stage of development, and people have passed the era of profiting from the destruction of the environment. There are already so many cost-effective and environmentally friendly alternative technologies that are emerging. This kind of thing is about to be abandoned. Otherwise, it won't be easily stolen. Do you think that the secrecy measures of those big companies are the same as in the movies, full of loopholes?

However, in our country, due to the speed and timing of development, there are still institutional limitations, so we are not allowed to export more advanced things that can enhance our national strength. Now the company's lawsuit is just a rabbit and piggybacking, and the foreign company, as an economic animal, will not miss any opportunity to make a profit.

Sha Baiyun grasped their main thoughts, so they had corresponding countermeasures. Sha Baiyun, who has been thinking about sustainable development, has paid attention to understanding the current foreign pharmaceutical patents and technologies, so knowing himself and knowing the other side will make the battle easy to fight.

Now the first thing is to respond to the lawsuit, and it is not uncommon for this kind of economic lawsuit to be fought for three or two years in a foreign country, and besides, I am not afraid of losing the lawsuit in the end, at most, I can't afford to pay and go bankrupt. I'm afraid that the other party will win the lawsuit and lose money at that time. You know, in China, the declaration of bankruptcy is a matter of paper, I am afraid that when the bankruptcy documents come out, this side will change its name and continue to produce, and it will not even be handed over.

Foreigners' companies also know the degree of tiredness and difficulty, they originally had the idea of how much they could, and they didn't have too much ambition. The initial condition was nothing more than a bluff. When Sha Baiyun and the others rushed there when they heard that the domestic company was going to respond to the lawsuit, the first thing they did when they met the other party's lawyer was to ask whether they could settle the agreement.

And they have come up with quite a lot of preferential conditions, although the original technology is OK, but it is already the initial version, and now they have relatively new achievements in their hands, and they still have a backlog of past equipment in their hands, which is in the mothballing stage, and they are preparing to find a place, and they want to sell it cheaply.

As a result, the two sides hit it off, and all the time was spent on business negotiations, no longer patent lawsuits. As for the withdrawal of the lawsuit, it is nothing more than a negotiation of document exchanges. The final result was unexpected, the other party withdrew the lawsuit, and after the three-year patent license period, it was directly transferred to the buyout, which was equivalent to installment payment, and the price was three years of patent royalties.

However, at this time, the pharmaceutical company was already in debt and could not make a big investment. So Sha Baiyun's eyes rolled, and it was another idea. The two sides organized a Sino-foreign joint venture company to jointly develop the domestic market, not only that, but in the initial lion's big opening, Sha Baiyun originally raised the inflated price of his value, and also let the other party agree to a part, and the other party was attracted by the expected profit in China, but took out a special amount of money to invest in the joint venture company in exchange for 49% of the shares of the joint venture company.

This makes people wonder, is the foreigner stupid? How can he go out to fight a lawsuit to compensate the other party, not only did he not pay for it, but only spent travel expenses, but brought back a large amount of equipment, and also brought back a sum of foreign exchange and a joint venture, not to mention, the other party also provided the latest environmentally friendly technology.

In fact, look at it, it's very simple, this is just a variant of the standard market for technology, some things that we don't look at are very valuable in foreign companies, for example, this time the most conspicuous is the pharmaceutical qualification in the factory, that is, the market access of a certain drug.

In the past, as a technology to fill the gap in China, drug licenses were issued quickly and at no cost, but in the eyes of foreigners, the price of this license was not the most valuable, but the most precious thing was the time saved.

You must know that even if a drug is licensed in another country, but to enter another country, it must be approved, and the prerequisite for approval is clinical testing, this process is necessary, and it also consumes a lot of money and time.

Therefore, this license alone is worth most of the domestic shares. As a result, there was a strange thing that everyone fell into the eyeballs, and the corresponding position of Sha Baiyun was also more solid for this reason. During that period, Liu Minghao's decline barely affected Sha Baiyun.

In this way, Sha Baiyun is like a fish in water, developing more rapidly, it didn't take many years, to pay off the loans and arrears, and the company has also developed greatly, now the pharmaceutical company not only has several pharmaceutical factories, but also has its own medicinal material cultivation base.

What is even more rare is that Sha Baiyun took precautions and took the opportunity of the foreign company to shrink the front to buy back the shares in their hands, so that Hantian Pharmaceutical has become a large state-owned enterprise again.

It was at this time that Liu Minghao began to find that Sha Baiyun had changed and become another person, a strong woman with a strong desire to dominate and possess, there may be an imbalance in this, Sha Baiyun has made great contributions to Hantian Pharmaceutical, it can be said that there is no Hantian Pharmaceutical without Sha Baiyun, but in the end, Hantian Pharmaceutical still belongs to the country, although as a management, Sha Baiyun also got some shares, but this is far from proportional to what he has paid in Sha Baiyun's view.